Supporting research across the full spectrum of medical sciences in Scotland

The Princess Royal Tenovus Scotland Medical Research Scholarship Programme

PrincessRoyal

The Princess Royal Tenovus Scotland Medical Research Scholarship has been established with the backing of our Patron, HRH The Princess Royal, to encourage new partnerships to support the work of Tenovus Scotland. The Fellowships will fund talented PhD students for 3/4 years of full time study.

The many young scientists and research minded clinicians we have hitherto been able to assist on to the ladder of medical research have been graduates with basic qualifications in science or medicine (BSc, MBChB, or similar ). As part of the path to becoming independent investigators they normally require higher qualifications such as a Mastership or a Doctorate (MSc, MD, PhD), the route to which requires secure funding in the form of a research scholarship. Such awards allow pursuit of full-time investigation with provision of stipend and support costs for laboratory and other expenses. Our new style of Scholarship is highly prestigious and will allow candidates of the highest calibre to engage in full-time study towards such goals.

We are therefore proposing that Scotland’s top businesses and trusts join our efforts to promote young medical or scientific researchers by sponsoring a named 3/4 years Scholarship for an outstanding candidate, at a fully inclusive cost of £90,000.

Sponsoring a Princess Royal Tenovus Scotland Medical Research Scholarship is an investment in the exceptional medical research performed in Scotland that has benefits across the globe. It is an investment in the young, creative minds that will one day solve many of the health issues that afflict our communities such as diabetes, cancer, heart disease, and many others.

The Princess Royal Tenovus Scotland Medical Research Scholarship is an opportunity for the businesses and trusts to demonstrate their community spirit in association with Scotland’s only independent charity for funding early studies in medical research.

• An independent, long-established research charity with an excellent track-record of allocating research funds
• A charity that works closely with Universities, teaching hospitals, and research scientists
• A charity that is best placed to match sponsor requirements with beneficiaries
• A charity with Royal and other high-level patronage and support

There are benefits for the business and trusts as well. These include:

• Brand association with a well-established and highly regarded Scottish medical charity
• Networking opportunities at events and meetings
• Recognition and company logo on our website and in publications
• Company brand promoted in the public domain through our activities at Science Centres, hospitals and medical research centres,
and other public outreach activities
• Exclusive listing on annual reports and marketing materials
• Invitations to, and promotion at, our full calendar of fundraising events including golf tournaments, bridge nights, dinners and music events

The inaugural award was presented at the Glasgow Science Centre by The Princess Royal to the University of Dundee who appointed Anna Mariano to study treatments for the early symptoms of Huntington’s disease.

Angela Ianniciello is the second person to receive the Princess Royal Tenovus Scotland Medical Research Scholarship. Angela is working on groundbreaking research into Chronic Myeloid Leukaemia and is based at the Wolfson Wohl Cancer Research Centre in the Institute of Cancer Sciences at the University of Glasgow. Angela said: “I am truly honoured to be awarded The Princess Royal Tenovus Scotland Medical Research Scholarship. Chronic myeloid leukaemia (CML) is a cancer in the blood and develops following a specific mutation in a bone marrow-located blood stem cell. These CML stem cells represent a crucial target for treatment. “The work already done by the University of Glasgow team is important because they have shown that CML stem cells are not killed with currently available drugs and can become resistant leading to relapse of patients. However, their previous work has also illustrated that autophagy (“self-eating”), a recycling process that maintains cell integrity, is an attractive target for CML stem cell eradication.” Angela started the scholarship in October 2015 under the supervision of Dr Vignir Helgason. Dr Helgason said “The main aim of Angela’s scholarship project is to further understand how autophagy controls the way in which CML stem cells function and use the best laboratory models, including patient-derived CML stem cells, to test new drugs that block autophagy. We hope that results from this project will lead to development of novel therapy options for CML and other stem cell driven leukaemias”.

©2016 Tenovus Scotland